Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis

Inflammatory Bowel Diseases

Volumn 17, Issue 2, 2011, Pages 680-681

  Yamamoto Furusho, Jesús K ^a   Peñaloza Coronel, Azucena ^a   Sánchez Muñoz, Fausto ^a   Barreto Zuñiga, Rafael ^a   Dominguez Lopez, Aarón ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

CLINICAL ARTICLE; DISEASE ACTIVITY; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION; HUMAN; LETTER; PRIORITY JOURNAL; REMISSION; ULCERATIVE COLITIS;

BIOPSY; COLITIS, ULCERATIVE; DOWN-REGULATION; HUMANS; PPAR GAMMA; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78651299907     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21322     Document Type: Letter

References (5)

1. Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology. 2003; 124: 1265-1276.
2. Shrestha UK, Karimi O, Crusius JB, et al. Distribution of peroxisome proliferator- activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010; 16: 312-319.
3. Atug O, Tahan V, Eren F, et al. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR gamma) gene in inflammatory bowel disease. J Gastrointest Liver Dis. 2008; 17: 433-437.
4. Wang F, Tahara T, Arisawa T, et al. Polymorphism of peroxisome proliferator-activated receptor gamma is not associated to Japanese ulcerative colitis. Hepatogastroenterology. 2008; 55: 73-75. (Pubitemid 351462166)
5. Lewis JD, Lichtenstein GR, Deren JJ, et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008; 134: 688-695.